Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy / 亚洲男科学杂志(英文版)
Asian Journal of Andrology
; (6): 387-392, 2019.
Article
en En
| WPRIM
| ID: wpr-1009706
Biblioteca responsable:
WPRO
ABSTRACT
Our previous study found that plate factor-4 variant (CXCL4L1) was downregulated in the serum of patients with prostate cancer (PCa). The aim of the present study was to investigate the prognostic value of CXCL4L1 in PCa. In total, 213 PCa patients treated with radical prostatectomy were enrolled and peripheral blood samples of all patients were collected. Expression of serum CXCL4L1 in patients with different tumor stages and grades were measured by enzyme-linked immunosorbent assay (ELISA). The Kaplan-Meier method was applied to estimate the progression to castration-resistant prostate cancer (CRPC), metastasis, biochemical recurrence (BCR)-free survival, and overall survival (OS). Prognostic factors for BCR-free survival and OS were determined by univariate and multivariate analyses using the Cox proportional hazards regression model. The expression of CXCL4L1 was significantly lower in PCa patients with advanced pathological tumor stage, high-grade Gleason score, and metastasis. Moreover, downregulation of CXCL4L1 not only strongly correlated with aggressive clinicopathological features, but also predicted tumor progression and unfavorable outcomes. Finally, multivariate Cox regression analyses identified CXCL4L1 as an independent prognostic factor for both BCR-free survival (hazard ratio [HR] 2.03, 95% confidence interval [CI] 1.26-3.27; P = 0.004) and OS (HR 2.26, 95% CI 1.07-4.79; P = 0.033). In conclusion, our results indicate that CXCL4L1 might serve as a novel and promising prognostic biomarker for patients with PCa and potential therapeutic target in the future.
Palabras clave
Texto completo:
1
Banco de datos:
WPRIM
Asunto principal:
Pronóstico
/
Próstata
/
Prostatectomía
/
Neoplasias de la Próstata
/
Factor Plaquetario 4
/
Adenocarcinoma
/
Regulación hacia Abajo
/
Tasa de Supervivencia
/
Supervivencia sin Enfermedad
/
Progresión de la Enfermedad
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Año:
2019
Tipo del documento:
Article